Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 May 25;7(2):240-4.
doi: 10.1159/000351877. Print 2013 May.

Acute liver failure associated with propylthiouracil in a pregnant 26-year-old woman

Affiliations
Case Reports

Acute liver failure associated with propylthiouracil in a pregnant 26-year-old woman

Tatsuo Miyamura et al. Case Rep Gastroenterol. .

Abstract

It seems appropriate to use propylthiouracil to treat maternal hyperthyroidism during the first trimester of pregnancy. We present the case of a 26-year-old woman with acute liver failure associated with propylthiouracil during the first trimester of pregnancy. She was successfully treated without liver transplantation. Attention should be paid to the possible occurrence of propylthiouracil-induced hepatotoxicity even during the first trimester of pregnancy.

Keywords: Acute liver failure; First trimester; Immune tolerance; Pregnancy; Propylthiouracil.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chart describing the course of ALT (black squares) and total bilirubin (black triangles) from the commencement of PTU administration until 1 week after discharge. ALT levels peaked at 531 IU/l. The total dose of PTU was 5,700 mg before admission. The patient improved after stopping PTU.
Fig. 2
Fig. 2
Liver biopsy showed normal architecture of the liver and no cirrhosis (hematoxylin and eosin; original magnification 40×) (a). Centrilobular necrosis was also found (hematoxylin and eosin; original magnification 200×) (b). We diagnosed the patient as drug-induced liver injury associated with PTU.

References

    1. Glinoer D, Cooper DS. The propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes. 2012;19:402–407. - PubMed
    1. Copper DS. Antithyroid drugs in the management of patients with Graves’ disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab. 2003;88:3474–3481. - PubMed
    1. Hackmon R, Blichowski M, Koren G. The safety of methimazole and propylthiouracil in pregnancy: a systemic review. J Obstet Gynaecol Can. 2012;34:1077–1086. - PubMed
    1. Morris CV, Goldstein RM, Cofer JB, Solomon H, Klintmalm GB. An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy. Clin Transpl. 1989;311 - PubMed
    1. Karras S, Tzotzas T, Krassas GE. Toxicological considerations for antithyroid drugs in children. Expert Opin Drug Metab Toxicol. 2011;7:399–410. - PubMed

Publication types

LinkOut - more resources